GSK to shut Dresden vaccine factory in 2027
Global Banking & Finance Review
GSK said it will close its Dresden vaccine factory in the summer of 2027; the facility produces traditional egg-based flu and hepatitis shots and the move would put 641 jobs at risk, the union IGBCE said. The works council and the union oppose the decision and plan to contest it. GSK plans to advance an mRNA seasonal influenza vaccine candidate to a late-stage trial after mid-stage data showed stronger immune responses than current shots, which may be driving a strategic shift away from egg-based production. The closure comes amid broader German factory restructuring announcements by Volkswagen.
GSK will close the Dresden vaccine plant in summer 2027.
Context
GSK announced a plan to close the Dresden plant that makes egg-based flu vaccines. The company will move an mRNA flu candidate into a late-stage trial. The union and works council oppose the closure and may seek to block or negotiate…
The full analysis
19 dimensions on this story — world impact, market read, and what happens next.
- Full ContextLocked
- Affected SectorsLocked
- Stock ImpactLocked
- Economic IndicatorLocked
- Investor RelevanceLocked
- Professional RelevanceLocked
- Watch PointsLocked
- Probability of ChangeLocked
- Debate PointsLocked
- Follow-up QuestionsLocked
- Pros & ConsLocked